Search, analyze & compare

Company details

Takeda Pharmaceutical Company Limited Sponsored ADR represents the interests of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company, in the United States. As a leading global biopharmaceutical company, Takeda focuses on providing transformative therapies in various areas such as oncology, gastroenterology, rare diseases, neuroscience, and plasma-derived therapies. The company's innovative history dates back to its founding in 1781, and it continues to drive leadership in research and development, with a robust pipeline of new therapies and drugs under exploration. By using the American Depositary Receipts (ADR) system, Takeda enables U.S. investors to easily gain exposure to its shares, which would otherwise be listed only in Japan. This strategic move enhances its accessibility in global financial markets while broadening its investor base. Takeda's commitment to addressing unmet medical needs and improving patient lives positions it as a critical player in the pharmaceutical industry, maintaining substantial influence across numerous therapeutic sectors worldwide.